Maximal Respiratory Pressures
Conditions
Interventions
This is a two-arm, double-blind, randomized controlled clinical study. Experimental group: 17 participants will perform inspiratory muscle training with the POWERbreathe® device with progressive load.
Sponsors
Hospital de Clínicas da Universidade Federal do Triângulo Mineiro
Universidade Federal do Triângulo Mineiro
Eligibility
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Patients diagnosed with heart failure; ventricular ejection fraction less than 40 percent; aged greater than or equal to 18 years; hospitalized for decompensated heart failure and clinically stable without the need for continuous ventilatory support
Exclusion criteria
Exclusion criteria: Decompensated lung diseases, pregnancy, head trauma, brain injury, cognitive impairment, neuromuscular disorders, hemodynamic instability with high dose of inotropes or acute coronary syndrome, presence of physical limitation that limits the performance of assessments and those who do not agree to sign the term of free and informed consent. Hemodynamic instability will be considered if systolic blood pressure is less than 90 mmHg or mean arterial pressure is less than 65 mmHg, peripheral hypoperfusion, heart rate is less than 40 or greater than 130 beats per minute, SpO2 is less than 88%, recent episodes of vomiting, complaints of dizziness or headache, high dose of dobutamine
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| An increase in exercise resistance and improvement in inspiratory muscle strength is expected in patients with acute heart failure | — |
Secondary
| Measure | Time frame |
|---|---|
| An increase in thickness and increased diaphragmatic mobility is expected | — |
Countries
Brazil
Contacts
Public ContactNoeme Soares
Hospital de Clínicas da Universidade Federal do Triângulo Mineiro
Outcome results
None listed